The global healthcare industry is facing one of its most pressing challenges—antimicrobial resistance (AMR). As conventional antibiotics steadily lose their effectiveness, the spotlight is shifting toward peptide antibiotics, a promising class of therapeutics offering novel mechanisms of action and improved efficacy against drug-resistant pathogens. This shift is positioning...

"Market Trends Shaping Executive Summary Peripheral Intravenous (IV) Catheter Market Size and Share The global peripheral intravenous (IV) catheter market size was valued at USD 1.96 billion in 2024 and is expected to reach USD 3.01 billion by 2032, at a CAGR of 5.50% during the forecast period Peripheral Intravenous (IV) Catheter report has been...

The effectiveness of central venous catheters (CVCs) in India is not solely determined by device quality but is heavily reliant on the adherence to stringent infection control protocols and the expertise of healthcare professionals. Addressing the high rate of nosocomial infections, particularly CLABSIs, requires continuous education and mandatory training on best practices for CVC insertion...

Bloodstream infections (BSIs), also referred to as bacteremia or septicemia depending on severity and clinical context, are serious medical conditions that occur when pathogenic microorganisms enter and circulate within the blood. Because the bloodstream connects all organs and tissues, infections in this system can rapidly progress and become life-threatening if not identified and treated...